In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.
The industry rank for SS Innovations International's Net-Net Working Capital or its related term are showing as below:
SSII's Price-to-Net-Net-Working-Capital is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 6.8 * Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.
SS Innovations International (NAS:SSII) Net-Net Working Capital Explanation
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.
SS Innovations International Net-Net Working Capital Related Terms
SS Innovations International Net-Net Working Capital Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SS Innovations International Net-Net Working Capital Chart
SSII vs BVS, TCMD, BBNX: Net-Net Working Capital Comparison
For the Medical Devices subindustry, SS Innovations International's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SS Innovations International Price-to-Net-Net-Working-Capital vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's Price-to-Net-Net-Working-Capital distribution charts can be found below:
* The bar in red indicates where SS Innovations International's Price-to-Net-Net-Working-Capital falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.
In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
This is a conservative way of estimating the company's value.
What does a Net-Net Working Capital of $0.00 mean?
SS Innovations International (SSII) has a Net-Net Working Capital of $0.00 as of Mar. 2026. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on SS Innovations International According to the industry distribution chart, SS Innovations International ranks #999999 out of 423 companies in the Medical Devices & Instruments industry.
Is SS Innovations International's Net-Net Working Capital too high?
SS Innovations International's current Net-Net Working Capital is $0.00. Based on the distribution chart, SS Innovations International ranks #999999 out of 423 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SS Innovations International has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SS Innovations International's Net-Net Working Capital compare to BVS and TCMD?
According to the Medical Devices & Instruments industry distribution chart, SS Innovations International ranks #999999 out of 423 companies for Net-Net Working Capital. This places SS Innovations International in the lower half of its industry. The industry median Net-Net Working Capital is 6.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net-Net Working Capital for a Medical Devices & Instruments company?
The median Net-Net Working Capital among Medical Devices & Instruments companies is 6.80, based on 423 companies in the industry. Companies in the top quartile (top 25%) have a Net-Net Working Capital significantly above this median, while those in the bottom quartile fall well below. However, Net-Net Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net-Net Working Capital mean?
A high Net-Net Working Capital can signal that a stock is expensive relative to its fundamentals. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on SS Innovations International For the Medical Devices & Instruments industry, the median Net-Net Working Capital is 6.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SS Innovations International's current Net-Net Working Capital is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SS Innovations International stock overvalued right now?
Based on GuruFocus' analysis, SS Innovations International (SSII) is currently considered Possible Value Trap. The stock's GF Value™ is $18.64, compared to a current price of $3.79 — trading 79.7% below its estimated fair value. The current Net-Net Working Capital is $0.00. SS Innovations International's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net-Net Working Capital calculated?
Net-Net Working Capital is calculated from a company's financial statements. For SS Innovations International (SSII), the current Net-Net Working Capital is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SS Innovations International (SSII) Overvalued in 2026?
Based on GuruFocus' analysis, SS Innovations International stock appears to be undervalued.
The current stock price of $3.79 is trading 79.7% below its estimated GF Value™ of $18.64.
GuruFocus considers SS Innovations International to be Possible Value Trap.
Key valuation signals for SSII:
Net-Net Working Capital: $0.00
GF Value™: $18.64 vs. price of $3.79 (79.7% below fair value)
No single metric tells the full story. See the SSII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
39GF Score
Get the complete analysis for SSII
Net-Net Working Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSII has been successfully added to your 
